Fibroblasts Influence Survival and Therapeutic Response in a 3D Co-Culture Model
RESEARCH ARTICLE
Fibroblasts Influence Survival and
Therapeutic Response in a 3D Co-Culture
Model
Meher Majety*, Leon P. Pradel, Manuela Gies, Carola H. Ries
Discovery Oncology, Roche Innovation Center Penzberg, Pharmaceutical Research and Early Development,
Penzberg, Germany
*
Abstract
OPEN ACCESS
Citation: Majety M, Pradel LP, Gies M, Ries CH
(2015) Fibroblasts Influence Survival and Therapeutic
Response in a 3D Co-Culture Model. PLoS ONE
10(6): e0127948. doi:10.1371/journal.pone.0127948
Academic Editor: Salvatore V Pizzo, Duke
University Medical Center, UNITED STATES
Received: October 1, 2013
Accepted: March 3, 2015
Published: June 8, 2015
Copyright: © 2015 Majety et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Funding: This study was funded internally by Roche
Diagnostics GmbH. The funder provided support in
the form of salaries for all authors, but did not have
any additional role in the study design, data collection
and analysis, decision to publish, or preparation of
the manuscript. The specific roles of these authors
are articulated in the author contributions section.
Competing Interests: The authors have the
following interests: This study was funded internally
by Roche Diagnostics GmbH, the employer of all
authors. The anti-IGF1R antibody (R1507) and the
anti-cMet antibody (Onartuzumab) are described in
the patents US7572897 titled “Antibodies against
Insulin-like growth factor I receptor and uses thereof”
In recent years, evidence has indicated that the tumor microenvironment (TME) plays a significant role in tumor progression. Fibroblasts represent an abundant cell population in the
TME and produce several growth factors and cytokines. Fibroblasts generate a suitable
niche for tumor cell survival and metastasis under the influence of interactions between fibroblasts and tumor cells. Investigating these interactions requires suitable experimental
systems to understand the cross-talk involved. Most in vitro experimental systems use 2D
cell culture and trans-well assays to study these interactions even though these paradigms
poorly represent the tumor, in which direct cell-cell contacts in 3D spaces naturally occur. Investigating these interactions in vivo is of limited value due to problems regarding the challenges caused by the species-specificity of many molecules. Thus, it is essential to use in
vitro models in which human fibroblasts are co-cultured with tumor cells to understand their
interactions. Here, we developed a 3D co-culture model that enables direct cell-cell contacts between pancreatic, breast and or lung tumor cells and human fibroblasts/ or tumorassociated fibroblasts (TAFs). We found that co-culturing with fibroblasts/TAFs increases
the proliferation in of several types of cancer cells. We also observed that co-culture induces
differential expression of soluble factors in a cancer type-specific manner. Treatment with
blocking antibodies against selected factors or their receptors resulted in the inhibition of
cancer cell proliferation in the co-cultures. Using our co-culture model, we further revealed
that TAFs can influence the response to therapeutic agents in vitro. We suggest that this
model can be reliably used as a tool to investigate the interactions between a tumor and the
TME.
Introduction
The tumor-stroma interaction has been identified as a hallmark of cancer[1]. The role of stromal cells in cancer progression has partially been elucidated, and several processes from growth
factor secretion to evading immune response have been attributed to the stromal cells. The
PLOS ONE | DOI:10.1371/journal.pone.0127948 June 8, 2015
1 / 18
Influence of Fibroblasts on Tumor Cell Growth
and US7476724 titled “Humanized anti-cMet
antibodies” respectively. There are no products in
development or marketed products to declare. This
does not alter the authors' adherence to all the PLOS
ONE policies on sharing data and materials, as
detailed online in the guide for authors.
ratio of tumor stroma has been shown to serve as an independent prognostic factor for breast
cancer patients that indicates a three-fold increased risk of relapse for stroma-rich tumors [2].
Further, stroma-related molecular signatures can be used to predict the resistance of breast cancer to neo-adjuvant chemotherapy [3]. A desmoplastic reaction involving a variety of stromal cell
types is often described as a distinct unique characteristic of pancreatic cancer [4]. Similarly, stromal cells have also been implicated in cancer progression and prognosis of lung cancer [5].
Fibroblasts constitute one of the most abundant cell types in the tumor stroma [6]. In normal tissues, fibroblasts play an important role in maintaining homeostasis and in wound healing by producing an array of factors that constitute the extracellular matrix (ECM) and other
growth factors and cytokines that are essential for healing [7]. The cross-talk between the
tumor cells and stromal fibroblasts in the TME influences to the secretion of an array of growth
factors and cytokine/chemokines that, in turn, support tumor cell growth or survival, induce
neo-vascularization and generate an immuno-suppressive TME in several cancers [8, 9]. Currently, TAFs appear to play a key role in tumor progression, and provide significant predictive
or prognostic value, as well as serve as potential therapeutic targets [10].
To understand the mechanisms underlying the cross-talk between tumor cells and TAFs in
vitro, a co-culture system in which tumor cells can interact with fibroblasts, similar to the TME
in situ, is required. Conventionally, trans-well chambers (Boyden chambers) are used for this
purpose. Using this approach, cells are separated by a porous membrane through which soluble
factors are able to diffuse freely but direct cell-cell interaction is absent. The importance of direct
cell-cell contact in this context has been demonstrated by experiments showing that the collagenbased co-culture of breast cancer cells with serum-activated fibroblasts induced clonogenic
growth in vitro [11]. Recently, it has been shown that the direct interaction between luminal-/
basal-like breast cancer cells and fibroblasts invokes distinct phenotypic and gene expression
changes that differ from trans-well co-cultures [12]. In addition, Fujita et al., showed that pancreatic cancer cell proliferation was enhanced by directly co-culturing these cells with pancreatic
stromal cells, allowing the two cell types to directly interact in the culture dishes [13]. However,
these studies were performed by culturing either one of the cell types on a flat 2D surface, which
hardly represents the complex TME in vivo. It has been clearly demonstrated that the 2D culture
system, although convenient for most applications, is a poor environment to study d (...truncated)